Package 43598-940-30

{"route": ["ORAL"], "spl_id": "641acdcc-9618-84e0-a09a-cbf956ffbe61", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["1436239", "1437278", "1437283", "1437288"], "spl_set_id": ["f07d81bc-5090-fbc5-2945-557cf002849c"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Dr. Reddys Laboratories Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43598-940-01)", "package_ndc": "43598-940-01", "marketing_start_date": "20260201"}, {"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43598-940-30)", "package_ndc": "43598-940-30", "marketing_start_date": "20260201"}], "brand_name": "Topiramate", "product_id": "43598-940_641acdcc-9618-84e0-a09a-cbf956ffbe61", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "43598-940", "generic_name": "Topiramate", "labeler_name": "Dr. Reddys Laboratories Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "50 mg/1"}], "application_number": "ANDA217231", "marketing_category": "ANDA", "marketing_start_date": "20260201", "listing_expiration_date": "20271231"}